E
EBOS Group Ltd
OTC:EBOSY
EBOS Group Ltd
OTC:EBOSY
Price:
37.69
USD
15.97%
Market Cap:
$7.3B
Relative Value
The Relative Value of one EBOSY stock under the Base Case scenario is 40.95 USD. Compared to the current market price of 37.69 USD, EBOS Group Ltd is Undervalued by 8%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
EBOSY
Relative Value
Base Case
40.95
USD
Undervaluation 8%
E
Multiples Across Competitors
EBOSY Competitors Multiples
EBOS Group Ltd Competitors
EBOS Group Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
E
|
EBOS Group Ltd
OTC:EBOSY
|
7.7B USD | 0.9 | 50.4 | 28.8 | 28.8 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
115.6B USD | 0.3 | 26.6 | 18.7 | 21 | |
| US |
|
Cencora Inc
NYSE:COR
|
69.9B USD | 0.2 | 43 | 15.1 | 19.1 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
69.9B USD | 0.2 | 43 | 15.1 | 19.1 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
52.2B USD | 0.2 | 31.4 | 15.1 | 19.6 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
31.6B AUD | 2.7 | 34.7 | 25.8 | 25.8 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
63.6B CNY | 0.2 | 11.3 | 15.2 | 15.2 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9B USD | 0.7 | 22.8 | 11.2 | 15.7 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
60.4B CNY | 1.4 | 16.3 | 12.6 | 12.6 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
65.3B HKD | 0.1 | 8.4 | 1.5 | 1.9 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
